chr8-144515395-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_004260.4(RECQL4):c.1321C>T(p.Pro441Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,612,772 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.1321C>T | p.Pro441Ser | missense_variant | 7/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.1321C>T | p.Pro441Ser | missense_variant | 7/21 | 1 | NM_004260.4 | ENSP00000482313 | P1 | |
RECQL4 | ENST00000621189.4 | c.250C>T | p.Pro84Ser | missense_variant | 6/20 | 1 | ENSP00000483145 | |||
RECQL4 | ENST00000532846.2 | c.208C>T | p.Pro70Ser | missense_variant | 3/9 | 5 | ENSP00000476551 | |||
RECQL4 | ENST00000688394.1 | n.344C>T | non_coding_transcript_exon_variant | 1/4 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152214Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000157 AC: 39AN: 247694Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134820
GnomAD4 exome AF: 0.000139 AC: 203AN: 1460440Hom.: 1 Cov.: 33 AF XY: 0.000135 AC XY: 98AN XY: 726488
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152332Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74464
ClinVar
Submissions by phenotype
Ovarian cancer Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University | Jan 01, 2022 | - - |
RECQL4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 31, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Baller-Gerold syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at